PHARMACEUTICAL manufacturer Hovid Bhd, en route to a second board listing on April 5, expects turnover to grow to RM145mil for the financial year ending June 30, from RM113mil a year earlier.
Last year’s group pre-tax profit was RM17.80mil, while pre-tax profit in 2005 is forecast at RM18.49mil.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
